STAT

OCTOBER 10, 2024

The director general of the Africa Centres for Disease Control and Prevention and Rwanda’s health minister on Thursday criticized the U.S. government’s decision to urge Americans to avoid travel to Rwanda because of the country’s ongoing Marburg outbreak. Calling the travel alert a travel ban — it is not — Jean Kaseya, who heads the Africa CDC, suggested the U.S. action was counterproductive and unfair to a country that is being transparent about its efforts to

336

336

PharmaVoice

OCTOBER 10, 2024

Although Regeneron has been playing catch-up in the oncology field for years, a pipeline built on next-wave promises could push the boundaries.

130

130

STAT

OCTOBER 10, 2024

Telehealth providers treating opioid use disorder, ADHD, and women’s health issues say the sector is in a state of frustration and chaos as the pandemic-era flexibilities that allowed their businesses to thrive are set to end with no new rules in sight. With just months to go before the ability to prescribe controlled substances online dramatically changes overnight, the vacuum of information is forcing them to devote significant energy preparing for the unknown.

Controlled Substances 336

Controlled Substances 336

PharmaVoice

OCTOBER 10, 2024

Despite the drug’s wide patient pool, Madrigal is taking a targeted approach with its first launch.

130

130

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

STAT

OCTOBER 10, 2024

Nearly 60% of the experts who reviewed manuscripts for four prominent medical journals received at least one payment from industry during a recent three-year period and, overall, these reviewers or their institutions received more than $1 billion from companies, according to a new analysis. Between 2020 and 2022, 1,155 of the 1,962 experts who reviewed studies for The BMJ, JAMA, The Lancet, and The New England Journal of Medicine received some form of payment.

Drug Development 331

Drug Development 331

BioPharma Dive

OCTOBER 10, 2024

In a letter to Pfizer’s board, the activist investor claimed former CEO Ian Read and CFO Frank D’Amelio were pressured to abandon a Starboard-led attempt to change the company’s direction.

112

112

The Pharmacist

OCTOBER 10, 2024

Concern has been raised over what have been described as 'incorrect and misleading' figures released today by the NHS Business Services Authority (NHSBSA) which suggest a record number of active dispensing contractors in several years. New data published by the NHSBSA claim that 2023/24 saw the 'highest number of active dispensing contractors since 2015/16'.

110

110

STAT

OCTOBER 10, 2024

Bill Nye the Science Guy is temporarily rebranding. For now, he’s “ Bill Nye the Ataxia Advocate Guy ,” as he aims to bring awareness to a neurological disease that has affected his family for generations. Nye has previously spoken about the genetic disease, which makes it difficult for people with the condition to control their muscles and often leads to problems with walking and speech, in a documentary released in 2017.

317

317

Express Pharma

OCTOBER 10, 2024

Aerogen, a global leader in acute-care aerosol drug delivery based in Ireland, and the Indian Association of Respiratory Care (IARC) have signed a Memorandum of Understanding (MoU) to advance respiratory therapy education and improve patient care throughout India. This collaboration focuses on elevating respiratory services and outcomes across the country.

Hospitals 98

Hospitals 98

STAT

OCTOBER 10, 2024

This story was first published in the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up  here  to get it delivered to their inbox. Sarepta Therapeutics CEO Doug Ingram is upset about the company’s slumping stock price.  Investors who have interacted with him this summer, including during a whitewater rafting trip, told me Ingram has been venting his frustration to anyone who will listen.

307

307

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

The Pharmacist

OCTOBER 10, 2024

A commissioned 'repeat prescription review' service in community pharmacy should be explored to improve medicines adherence and patient understanding, the Royal Pharmaceutical Society (RPS) and Royal College of GPs (RCGP) have suggested. The recommendation comes as part of a new repeat prescribing toolkit, in what is believed to be the first guidance of its kind […] The post Community pharmacy repeat prescription review service ‘should be explored’ appeared first on The Pharmacist.

Community Pharmacies 106

Community Pharmacies 106

STAT

OCTOBER 10, 2024

In the largest settlement of its kind, Teva Pharmaceuticals agreed to pay $425 million to resolve allegations the company and a related business paid kickbacks to charitable foundations in order to boost usage of a pricey medicine. Separately, the drugmaker agreed to pay $25 million to settle charges of participating in a price-fixing scheme with other generic companies.

Pharmaceutical Companies 296

Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 296

pharmaphorum

OCTOBER 10, 2024

Media personality Nadia Sawalha is heading a fundraising effort to launch an appeal against NICE's recent rejection of a breast cancer therapy Enhertu.

110

110

STAT

OCTOBER 10, 2024

Over the past decade, there has been a clear and unprecedented exodus of young life scientists from academia and into lucrative industry jobs. But new data provide evidence that this trend is slowing, at least for now. The latest numbers from the Survey of Earned Doctorates, an annual National Science Foundation census of freshly minted Ph.D. graduates, show that 61.6% of biomedical scientists who had a job lined up were bound for industry in 2023.

281

281

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

Express Pharma

OCTOBER 10, 2024

Alkem Laboratories, has entered into a licensing agreement with US-based Sonnet BioTherapeutics Holdings to develop, manufacture and commercialise the drug candidate SON-080 for the treatment of diabetic peripheral neuropathy in India. SON-080 is Sonnet’s proprietary version of “atexakin alfa”. It has shown encouraging data in phase 1b clinical trial.

Diabetes 96

Diabetes Chemotherapy 96

STAT

OCTOBER 10, 2024

How does John Maraganore decide which startups to get involved in? Why are longevity-minded tech bros getting involved with a controversial CRISPR scientist? And who would you rather hang out with at the STAT Summit next week, Adam or Allison? We discuss all that and more on this week’s episode of “The Readout LOUD,” STAT’s biotech podcast.

278

278

pharmaphorum

OCTOBER 10, 2024

Ono Pharma and Boehringer Ingelheim both added to their cancer pipelines, licensing drugs from LigaChem Bio and Circle Pharma, respectively.Ono's deal with South Korean antibody-drug conjugate (ADC) specialist LigaChem is worth up to $700 million and covers a license to a preclinical-stage candidate for solid tumours, as well as an R&D collaboration to seek out other ADC candidates.

100

100

STAT

OCTOBER 10, 2024

On Thursday, the CDC released new data showing that almost 15.5 million U.S. adults are living with ADHD. More than half of those individuals received their diagnosis in adulthood.   That includes me. The diagnosis came as a relief and validation — a way to understand years of impulsivity, inattention, and struggles with daily life. I was diagnosed at age 36, after first one, then two, and ultimately, four of my five children were also diagnosed with ADHD.

278

278

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Express Pharma

OCTOBER 10, 2024

Daiichi Sankyo has recently announced the final two-year follow-up data from the German cohort of the MILOS study. The MILOS study is a real-world investigation into the use of bempeodoic acid for managing high cholesterol levels. Bempedoic acid and its fixed dose combination with ezetimibe, with or without other lipid therapies, have been shown to significantly reduce low-density lipoprotein cholesterol (LDL) levels in patients with hypercholesterolemia or mixed dyslipidaemia.

90

90

STAT

OCTOBER 10, 2024

This story first appeared in The Readout newsletter.  Sign up for The Readout  and receive STAT’s award-winning biotech news delivered straight to your inbox.  Morning. Today, we are sad to report that more children have developed blood cancers after receiving Bluebird Bio’s CALD gene therapy, Skysona. There’s a new twist in the Pfizer activist shareholder campaign.

Drug Pricing 278

Drug Pricing Drug Development 278

European Pharmaceutical Review

OCTOBER 10, 2024

A draft joint EU network strategy to 2028 has been published by the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA). This is updated strategy replaces the original five-year strategy, which was developed to cover from 2021 to 2025 (EMANS 2025). Revised strategy – adapting to change The draft strategy covers the following focus areas up to 2028: Accessibility to support pathways for medicine access in the EU Leveraging data, digitalisation and artificial intelligen

98

98

STAT

OCTOBER 10, 2024

U.S. Sen. Elizabeth Warren has asked the Federal Trade Commission “closely scrutinize” a $16.5 billion deal in which Novo Nordisk’s parent foundation would acquire Catalent, a leading contract drug manufacturer, over concerns the acquisition would give the pharmaceutical company an unfair advantage in the burgeoning market for drugs used to treat obesity and diabetes.

Packaging 273

Packaging Diabetes Pharmaceutical Companies Pharmaceutical Companies 273

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Outsourcing Pharma

OCTOBER 10, 2024

The big pharma company AstraZeneca has forged a licensing pact worth $2 billion with the Chinese firm CSPC Pharmaceutical Group for access to an experimental small molecule treatment for dyslipidemia.

98

98

STAT

OCTOBER 10, 2024

The ink had scarcely dried on  new federal rules  for enforcement of the Mental Health Parity and Addiction Equity Act of 2008 when U.S. health plans  threatened potential legal action  to block them.  Buoyed by a recent Supreme Court ruling that  shifts power away from federal agencies , health plans apparently hope to keep the departments of Labor, Treasury, and Health and Human Services from making parity a reality, years after Congress passed the law with r

235

235

pharmaphorum

OCTOBER 10, 2024

Starboard Value alleges former Pfizer execs Ian Read and Frank D'Amelio were bullied into lending their support to current management

111

111

STAT

OCTOBER 10, 2024

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. We’ve got a hurricane-centric newsletter for you this morning. I am writing this hours before Milton makes landfall — stay safe, everyone.

Hospitals 252

Hospitals 252

The Pharmacist

OCTOBER 10, 2024

The clinical pathways delivered under Pharmacy First are a 'good starting point' to define the scope of practice for Physician Associates (PAs), the Royal College of GPs (RCGP) has said. Pharmacists must undertake additional training to deliver minor ailments consultations under Pharmacy First. But the RCGP suggested that 'first point of contact presentations' of over […] The post Pharmacy First 'good starting point' for PA scope of practice, says RCGP appeared first on The Pharm

96

96

STAT

OCTOBER 10, 2024

Top of the morning to you and a fine one it is. Blue skies, cool breezes, and plenty of chirping birds are enveloping the comfy Pharmalot campus, which is cause to fire up the coffee kettle for yet another cup of stimulation. Our choice today is strawberry creme — sweets for the sweet, you know. Meanwhile, we have assembled the latest menu of tidbits for you to peruse.

Compounding 252

Compounding 252

Express Pharma

OCTOBER 10, 2024

Jubilant Biosys Innovative Research Services (JBIRSPL), Singapore, subsidiary of Jubilant Biosys, a wholly owned subsidiary of Jubilant Pharmova and Pierre Fabre SA are entering in a strategic partnership. Pursuant to this, JBIRSPL would acquire 80 per cent equity capital in Jasmin (new company incorporated in France, as a Société par Actions Simplifiée (SAS), 100 per cent owned by Pierre Fabre).

77

77

STAT

OCTOBER 10, 2024

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences.  Sign up to get it  delivered in your inbox every Tuesday and Thursday. Lilly appoints Chief AI Officer Drug giant Eli Lilly announced Thomas Fuchs as its first chief AI officer. Previously, Fuchs was director of the Hasso Plattner Institute for Digital Health at Mount Sinai in New York where he helped lead work on computational pathology.

250

250

Drug Patent Watch

OCTOBER 10, 2024

China has emerged as a significant player in the global generic drug active pharmaceutical ingredient (API) market. The country’s vast production capacity, low costs, and strategic location have made it an attractive destination for pharmaceutical companies seeking to source APIs.

Pharmaceutical Companies 84

Pharmaceutical Companies Pharmaceutical Companies 84

Outsourcing Pharma

OCTOBER 10, 2024

Evaxionâs proprietary AI-Immunology platform has shown in clinical trials that it can select clinically relevant cancer vaccine targets.

Vaccines 97

Vaccines 97